GlassScriptPhysician profile
Heidi Danielle Lencoski
NPI 1174706170
$2,108.54
in general payments reported to CMS, 2019-2025
25 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $480 · 2020: $306 · 2021: $679 · 2022: $219 · 2023: $227 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $496.56 | 2019-2023 | |
| Therapeuticsmd, INC. | $223.70 | 2019-2022 | |
| Avion Pharmaceuticals | $167.63 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $126.23 | 2019-2021 | |
| Kci USA, INC. | $125.00 | 2019 | |
| Meditrina | $123.76 | 2022-2025 | |
| Agile Therapeutics, INC. | $108.29 | 2021-2023 | Twirla |
| Astellas Pharma US INC | $102.59 | 2019-2023 | Myrbetriq, Veozah |
| Medtronic, INC. | $91.38 | 2025 | Interstim |
| Pfizer INC. | $80.73 | 2022-2023 | |
| Mayne Pharma Commercial LLC | $75.05 | 2021-2023 | |
| Allergan, INC. | $68.74 | 2019-2020 | |
| Exeltis, USA INC. | $47.67 | 2020-2021 | |
| Radius Health, INC. | $37.09 | 2020 | |
| Hologic Sales and Service, LLC | $34.79 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $31.45 | 2019-2020 | |
| Myovant Sciences INC. | $29.10 | 2021 | |
| Amag Pharmaceuticals, INC. | $28.00 | 2019 | |
| Daiichi Sankyo INC. | $19.92 | 2021 | |
| Sage Therapeutics, LLC | $17.95 | 2023 | |
| Merck Sharp & Dohme LLC | $17.03 | 2021 | |
| Glaxosmithkline, LLC. | $15.58 | 2023 | Shingrix |
| Boston Scientific Corporation | $15.44 | 2019 | |
| Scynexis, INC. | $12.76 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Lencoski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.